Invention Grant
- Patent Title: Salts of a PD-1/PD-L1 inhibitor
-
Application No.: US16987557Application Date: 2020-08-07
-
Publication No.: US11753406B2Publication Date: 2023-09-12
- Inventor: Zhongjiang Jia , Pingli Liu , David J. Meloni , Yongchun Pan , Yongzhong Wu , Jiacheng Zhou , Qun Li
- Applicant: Incyte Corporation
- Applicant Address: US DE Wilmington
- Assignee: Incyte Corporation
- Current Assignee: Incyte Corporation
- Current Assignee Address: US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K9/00
Abstract:
The present invention relates to salt forms of the PD-1/PD-L1 inhibitor (R)-1-((7-cyano-2-(3′-(3-(((R)-3-hydroxypyrrolidin-1-yl)methyl)-1,7-naphthyridin-8-ylamino)-2,2′-dimethylbiphenyl-3-yl)benzo[d]oxazol-5-yl)methyl)pyrrolidine-3-carboxylic acid, including methods of preparation thereof, where the compound is useful in the treatment of various diseases including infectious diseases and cancer.
Public/Granted literature
- US20210040090A1 SALTS OF A PD-1/PD-L1 INHIBITOR Public/Granted day:2021-02-11
Information query
